This PubMed-listed in vitro study tested whether 1800 MHz RF-EMF exposure can modify chemically induced DNA damage in mouse embryonic fibroblasts under standardized, non-thermal conditions. The authors report RF-EMF alone did not produce detectable DNA damage and did not significantly increase damage from hydrogen peroxide, 4-nitroquinoline-1-oxide, or cadmium. However, co-exposure with hexavalent chromium (Cr(VI)) was reported to synergistically increase DNA damage in the comet assay, which the authors interpret as possible selective exacerbation of Cr(VI)-induced genotoxicity requiring further investigation.

RF Safe argues that Media Bias/Fact Check (MBFC) downgraded RF Safe partly by citing an FDA webpage stating typical RF exposure is not supported by current evidence as a health risk, but that the cited FDA page now redirects to a general “Cell Phones” landing page. The post claims other historically cited FDA consumer pages also redirect and that the strongest reassurance language is now mainly accessible via archives. It further cites Reuters reporting that FDA removed outdated webpages about cellphone safety alongside HHS launching a new study, and contends MBFC should update its rationale and links.

This RF Safe commentary argues that HHS, under Secretary Robert F. Kennedy Jr., was correct to remove FDA webpages that gave broad assurances that cell phone radiation is “not dangerous.” It claims blanket safety messaging is scientifically indefensible given animal toxicology findings (notably the U.S. National Toxicology Program studies), a WHO-commissioned systematic review of animal cancer studies (Mevissen et al., 2025), and references to federal court findings. The piece frames the change as a precautionary, science-based correction rather than an anti-science move.

This RF Safe commentary argues that if HHS and FDA pursue a “reset” on cellphone radiation policy, they should fund mechanistic, predictive biology rather than relying on literature summaries or general safety reassurances. It cites the NTP rat bioassays and a WHO-commissioned animal cancer systematic review (Mevissen et al., 2025) as motivation, emphasizing reported tissue-selective findings and non-monotonic dose patterns. The post proposes a mechanistic framework (“S4–Mito–Spin”) and calls for research to map boundary conditions across tissues and exposure parameters to inform standards beyond SAR/thermal assumptions.

This RF Safe commentary argues that dismissing the National Toxicology Program (NTP) cellphone-radiation animal findings as “too high dose” is misleading because the NTP used multiple exposure tiers, including a lowest tier described as near regulatory relevance. It also claims FDA has removed webpages containing prior “safety conclusion” language while HHS has announced a new study on electromagnetic radiation and health effects, framing these as a meaningful shift in federal public-facing posture. The piece further points to the Ramazzini Institute animal study as suggesting similar tumor signals at lower exposure levels, while acknowledging animal studies alone do not establish human causation.

RF Safe argues that “anti-radiation” phone case marketing based on universal “99% blocking” claims is misleading because real-world phone emissions vary with signal conditions, orientation, and how a case affects the antenna. The post positions RF Safe’s TruthCase/QuantaCase as more credible specifically because it refuses to advertise a single percentage reduction and instead emphasizes design constraints intended to avoid prompting a phone to increase transmit power. It cites a KPIX 5 (CBS San Francisco) test as an example of how flip cases can reduce exposure in some configurations but potentially increase it in others when used differently than intended.

RF Safe publishes a rebuttal to Media Bias/Fact Check’s January 8, 2026 update that labeled RF Safe “Least Biased” and “Mostly Factual” but assigned “Medium Credibility,” citing perceived one-sided interpretation, product-sales conflicts, and alarmist framing. The post argues RF Safe’s “S4-Mito-Spin” framework incorporates null findings as boundary conditions to explain variability in RF/EMF study outcomes rather than ignoring negative results. It also claims major authorities’ positions are outdated in light of a cited WHO review and a U.S. court remand regarding FCC guidelines, and contends product sales are secondary to advocacy and education.

This RF Safe commentary frames readers as part of a “resistance” movement seeking changes to U.S. wireless policy and RF exposure governance. It argues that current FCC RF exposure rules and related laws constrain local decision-making and rely on a “thermal-only” safety framework that the author says is outdated. The post cites a WHO-commissioned 2025 systematic review on RF-EMF and cancer in experimental animals as part of a broader WHO review effort, and advocates shifting indoor connectivity toward light-based technologies.

RF Safe argues that its “S4-Mito-Spin” framework should avoid debates about whether cell phones cause human disease and instead focus on mechanistic and animal evidence for non-thermal RF/EMF biological effects. The post claims the framework synthesizes established concepts (ion-channel interactions, mitochondrial/NOX-driven ROS, and radical-pair/quantum spin effects) to explain why some lab studies find effects and others do not. It also cites a WHO-commissioned systematic review and a U.S. court ruling to support calls for updating RF exposure guidelines beyond thermal-only assumptions.

RF Safe argues that its “S4-Mito-Spin” framework should avoid human disease causation debates and instead focus on interpreting non-thermal RF/EMF findings from cellular and animal studies. The article claims the framework synthesizes mechanisms involving voltage-gated ion channels, mitochondrial/oxidative stress pathways, and radical-pair (spin) effects to explain why some experiments show effects and others do not. It further contends that rodent evidence and a cited WHO-commissioned review support updating RF exposure guidelines beyond thermal-only assumptions, and references a U.S. court decision criticizing the FCC’s rationale for maintaining existing limits.

RF Safe publishes a rebuttal to Media Bias Fact Check’s (MBFC) decision to rate the site “Medium Credibility,” addressing MBFC’s concerns about selective citation, one-sided interpretation, alarmist framing, and potential conflicts of interest tied to selling RF-safety products. The post argues RF Safe includes null/negative findings, avoids claiming RF “causes” specific diseases, and maintains editorial/transparency policies meant to separate evidence types and disclose commercial relationships. It also contends MBFC’s critique is partly a dispute over tone and wording (e.g., “primarily” funded by product sales) rather than demonstrated sourcing errors.

RF Safe argues that “no effect” (null) findings in RF research should be treated as informative constraints rather than dismissed, within its S4–Mito–Spin mechanistic framework. The post claims biological and exposure heterogeneity can produce nonlinear, tissue- and signal-dependent outcomes, making null results an expected pattern under many study conditions. It references a WHO-commissioned systematic review on RF-EMF and oxidative stress biomarkers as concluding the evidence is of “very low certainty,” citing bias, heterogeneity, and exposure/measurement limitations.

RF Safe publishes a rebuttal to Media Bias Fact Check’s (MBFC) January 8, 2026 credibility assessment, arguing MBFC’s “Medium Credibility” rating is unjustified despite MBFC upgrades to “Least Biased” and “Mostly Factual.” The post disputes MBFC’s criticisms (selective citation, alarmist framing, and potential conflict of interest from product sales) and claims RF Safe’s coverage aligns with WHO-commissioned reviews and legal/regulatory developments. RF Safe reiterates its view that thermal-only RF exposure guidelines are inadequate and calls for policy reform while stating it does not claim definitive human causation.

RF Safe publishes a rebuttal to Media Bias Fact Check (MBFC) after MBFC labeled RF Safe as “pseudoscience” with “mixed factual reporting” and “low credibility.” The article argues MBFC made factual errors about RF Safe’s research links and ownership/funding, and says MBFC has not corrected the entry despite requests. RF Safe also defends its framing of non-thermal RF/EMF effects as precautionary and grounded in peer-reviewed literature, while criticizing what it characterizes as superficial fact-checking.

RF Safe argues that celebrity-branded mobile services (citing reported plans for “Beast Mobile” and the announced “Trump Mobile”) could normalize near-body, all-day phone use—especially among children—and therefore carry ethical responsibility for scaled RF exposure. The piece cites legal and scientific developments (including the 2021 Environmental Health Trust v. FCC decision, the U.S. NTP animal studies, and a WHO-commissioned systematic review) to claim the evidence base has “moved decisively” toward concern about long-term RF-EMF effects. It also promotes a proposed mechanistic framework ("S4–Mito–Spin") and suggests shifting indoor connectivity toward Li‑Fi (IEEE 802.11bb) as a harm-reduction approach.

This RF Safe commentary argues that U.S. RF exposure protections remain anchored to “thermal-only” assumptions from the 1990s despite what it describes as newer WHO-commissioned systematic reviews elevating certain animal cancer endpoints and a male fertility endpoint to “high certainty.” It contrasts these claims with a WHO-commissioned review of human observational studies that reportedly found mobile-phone RF exposure is likely not associated with increased risk of several head/brain tumors, arguing that this is often overgeneralized in public messaging. The piece calls for “prudent avoidance,” updates to FCC rules, and highlights legal and policy constraints such as federal preemption under the Telecommunications Act and a 2021 D.C. Circuit decision criticizing the FCC’s rationale for retaining its RF limits without adequate explanation.

RF Safe argues that recent WHO-linked evidence reviews have moved beyond a “thermal-only” safety narrative and that policy should respond with stronger protections. The post cites a 2025 WHO-commissioned systematic review in Environment International as concluding with “high certainty” that RF-EMF increases malignant heart schwannomas and brain gliomas in male rats, and references a 2025 corrigendum upgrading certainty for reduced pregnancy rates after male RF exposure in animal experiments. It also points to U.S. FCC rules being rooted in 1996-era assumptions and references a U.S. appellate court remand requiring the FCC to better address non-cancer harms and impacts on children and long-term exposure. The article advocates for the “Clean Ether Act” and promotes RF Safe’s proposed “S4–Mito–Spin” mechanism framework as a non-thermal explanatory model.

RF Safe promotes an “Act Now” hub intended to convert EMF safety concerns into policy and regulatory actions, emphasizing accountability and exposure reduction, especially for children. The page outlines five advocacy “levers,” including changing Section 704 of the Telecommunications Act, pressing the FCC to complete actions following a court remand, and restarting a federal electronic-product radiation program. It frames current RF oversight as outdated and insufficient for modern exposure patterns, and provides scripts to help supporters submit comments and demands into official records.

This article summarizes expert presentations and a panel discussion on radiological protection systems for ionizing and non-ionizing radiation at an international congress. It highlights that ionizing radiation protection is mature and continually revised, while non-ionizing radiation protection lacks a comparable international framework. The authors emphasize that emerging non-ionizing technologies create complex exposure scenarios and unresolved concerns about chronic and acute exposures, calling for a more cohesive and protective framework.

This animal study tested whether short-term 28 GHz (5G-band) millimeter-wave exposure modifies doxorubicin-induced cardiotoxicity in male rats and whether vitamin C mitigates effects. Co-exposure to 28 GHz EMR was reported to worsen several indices of DOX-related cardiac injury (including CAT reduction, increased BAX expression, and QT prolongation), while vitamin C provided partial attenuation. The authors emphasize that results are limited to a short-duration preclinical model and that human relevance remains preliminary.

This magazine article discusses the rising incidence of thyroid cancer and raises the possibility of an association with increased smartphone use and related RF EMF exposure near the head and neck. It characterizes EMF exposure from personal electronics as a growing public health concern. The piece calls for more research, monitoring, and public awareness, and mentions precautionary measures.